FDA Approves Drug To Treat Fabry Disease.

Reuters (8/10, Respaut) reported that on Friday, the FDA approved Amicus Therapeutics’ Galafold (migalastat), the “first oral therapy to treat Fabry disease, a rare sometimes fatal condition in which accumulation of fat damages several organs.” This is t...